The top 10 medtech M&A deals of 2021

The top 10 medtech M&A deals of 2021

Source: 
Fierce Biotech
snippet: 

After the medtech world halted during the early stages of the pandemic—with many pivoting to respond to the global demand for ventilator hardware and diagnostic tests—M&A activity picked back up with a bang in the latter half of 2020.

Looking to make up for lost time and hopefully prepare companies for a new life in a post-COVID landscape, dealmaking kept that pace through the first half of 2021 and then some. Logging about $31.5 billion in transactions over the first six months of the year alone, the medtech sector overtook the $28.8 billion M&A total it saw for all of 2020, according to figures from Evaluate Medtech.